Pura Vida Investments, LLC Rocket Pharmaceuticals, Inc. Transaction History

Pura Vida Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $618,500 - $920,500	50,000 New	50,000 $798,000
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $1.06 Million - $2.74 Million	-109,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $1.21 Million - $2.64 Million	109,000 New	109,000 $2.48 Million
Q3 2018 Nov 14, 2018	SELL	$18.5 - $25.49 $951,991 - $1.31 Million	-51,459 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$14.58 - $23.0 $291,600 - $460,000	-20,000 Reduced 27.99%	51,459 $1.01 Million
Q1 2018 May 14, 2018	BUY	$11.68 - $19.19 $834,641 - $1.37 Million	71,459 New	71,459 $0

209

93.1M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $809M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.